EyePoint (EYPT) Other financing activities (2011 - 2026)
EyePoint (EYPT) reported Other financing activities of $606000.0 for Q1 2026, up 170.54% on a YoY basis from $224000.0 in Q1 2025, and up 72.65% sequentially from $351000.0 in Q4 2025.
EyePoint (EYPT) Other financing activities (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 14 years of Other financing activities data on file, last reported at $606000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 170.54% year-over-year to $606000.0; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (up 55.45% YoY), and the FY2025 full-year result was $1.5 million, down 73.39% from the prior year.
- Other financing activities advanced to $606000.0 in Q1 2026, from $351000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $4.6 million in Q1 2024 to a low of -$354000.0 in Q4 2022.
- A 5-year average of $662562.5 and a median of $262000.0 in 2024 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities sank 497.75% in 2022 and surged 12400.0% in 2024, its largest moves.
- Tracing EYPT's Other financing activities over 5 years: stood at -$354000.0 in 2022, then jumped by 636.44% to $1.9 million in 2023, then tumbled by 95.16% to $92000.0 in 2024, then soared by 281.52% to $351000.0 in 2025, then soared by 72.65% to $606000.0 in 2026.
- Business Quant data shows EYPT's Other financing activities at $606000.0 in Q1 2026, $351000.0 in Q4 2025, and $623000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 606,000.00 |
| Mar 31, 2026 | 606,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Sep 30, 2025 | 623,000.00 |
| Sep 30, 2025 | 623,000.00 |
| Jun 30, 2025 | 273,000.00 |
| Jun 30, 2025 | 273,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 251,000.00 |
| Sep 30, 2024 | 251,000.00 |
| Jun 30, 2024 | 625,000.00 |
| Jun 30, 2024 | 625,000.00 |
| Mar 31, 2024 | 4.56 Mn |
| Mar 31, 2024 | 4.56 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Dec 31, 2023 | 1.90 Mn |